- Zacks•5 hours ago
With third quarter earnings season off to a start, investor focus remains on the performance of biotech stocks like Amgen (AMGN) and Celgene (CELG) which will be reporting results this week.
- 24/7 Wall St.•yesterday
While worries about interest rates increases remain, it looks as though growth stocks still are the best avenue heading into the final two months of the year.
- Investor's Business Daily•2 days ago
Alkermes and Lundbeck are cannibalizing Johnson & Johnson's anti-psychosis sales, Credit Suisse said Monday.
Alkermes plc (ALKS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||53.06 x 100|
|Ask||53.15 x 200|
|Day's Range||52.68 - 55.73|
|52wk Range||27.14 - 80.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-28.93|
|Avg Vol (3m)||1,064,449|
|Dividend & Yield||N/A (N/A)|